CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
CVS HEALTH Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$92.68+0.32 (+0.35%)
Close on Oct 19, 2026
- Market cap
- $119.28B
- P/E (TTM)
- 24.6
- Dividend yield
- 2.87%
Cvs Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Retail-Drug Stores and Proprietary Stores companies for comparison
Valuation
| Measure | Cvs Health | Industry median |
|---|---|---|
| Market Cap | $118.54B | $123.11M |
| Enterprise Value | $166.18B | $132.88M |
| PE Ratio | 24.58 | 20.64 |
| PS Ratio | 0.29 | 0.58 |
| PB Ratio | 1.49 | 1.75 |
| P/FCF Ratio | 10.08 | 13.72 |
| P/OCF Ratio | 8.02 | 10.25 |
Enterprise value
| Measure | Cvs Health | Industry median |
|---|---|---|
| EV / Sales | 0.40 | 0.61 |
| EV / EBITDA | 12.97 | 12.09 |
| EV / EBIT | 20.05 | 14.62 |
| EV / FCF | 14.13 | 18.07 |
Income (trailing twelve months)
| Measure | Cvs Health | Industry median |
|---|---|---|
| Revenue | $415.09B | $366.90M |
| Gross Profit | $184.68B | $250.49M |
| Operating Income | $8.29B | -$275.87K |
| Pretax Income | $5.79B | -$646.71K |
| Net Income | $4.89B | -$948.56K |
| EBITDA | $12.81B | $185.52K |
| EPS (Diluted) | $3.77 | $0.00 |
Margins
| Measure | Cvs Health | Industry median |
|---|---|---|
| Gross Margin | 44.5% | 39.8% |
| Operating Margin | 2.00% | -0.44% |
| Pretax Margin | 1.39% | -0.66% |
| Profit Margin | 1.18% | -0.34% |
| EBITDA Margin | 3.09% | 1.22% |
| FCF Margin | 2.83% | 1.51% |
Returns
| Measure | Cvs Health | Industry median |
|---|---|---|
| Return on Equity (ROE) | 6.23% | -6.32% |
| Return on Assets (ROA) | 1.91% | -2.25% |
| Return on Invested Capital (ROIC) | 5.45% | -2.51% |
| Return on Capital Employed (ROCE) | 4.97% | 0.09% |
Growth
| Measure | Cvs Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 7.36% | 5.86% |
| Net Income Growth (YoY) | 7.92% | 7.00% |
| EPS Growth (YoY) | 5.31% | 5.26% |
| FCF Growth (YoY) | 146.0% | 19.4% |
| Revenue Growth (3Y CAGR) | 7.63% | -1.38% |
| Revenue Growth (5Y CAGR) | 8.39% | 4.80% |
| EPS Growth (3Y CAGR) | -24.7% | -1.16% |
| EPS Growth (5Y CAGR) | -23.9% | 8.19% |
Balance sheet
| Measure | Cvs Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $13.96B | $22.34M |
| Total Debt | $61.41B | $63.88M |
| Net Cash (Debt) | -$47.45B | $10.47K |
| Net Cash Per Share | -$37.10 | $0.00 |
| Equity (Book Value) | $79.70B | $22.99M |
| Book Value Per Share | $62.32 | $0.92 |
| Tangible Book Value | -$30.42B | $2.81M |
| Working Capital | -$11.70B | $3.42M |
Financial position
| Measure | Cvs Health | Industry median |
|---|---|---|
| Current Ratio | 0.87 | 1.15 |
| Quick Ratio | 0.62 | 0.44 |
| Debt / Equity | 0.77 | 0.49 |
| Debt / EBITDA | 4.79 | 2.93 |
| Debt / FCF | 5.22 | 3.74 |
| Net Debt / EBITDA | 3.70 | 1.53 |
| Interest Coverage | 2.67 | -0.20 |
Cash flow (trailing twelve months)
| Measure | Cvs Health | Industry median |
|---|---|---|
| Operating Cash Flow | $14.78B | $1.90M |
| Capital Expenditures | -$3.02B | -$11.69M |
| Free Cash Flow | $11.76B | $9.09M |
| FCF Per Share | $9.19 | $0.30 |
Efficiency
| Measure | Cvs Health | Industry median |
|---|---|---|
| Asset Turnover | 1.62 | 1.46 |
| Inventory Turnover | 13.14 | 5.74 |
| Revenue Per Employee | $1.38M | $473.82K |
| Profits Per Employee | $16.30K | -$6.50K |
| Employee Count | 300,000 | 361 |
Dividends and yields
| Measure | Cvs Health | Industry median |
|---|---|---|
| Earnings Yield | 4.13% | -2.14% |
| FCF Yield | 9.92% | 3.12% |
| Dividend Yield | 2.87% | 1.10% |
| Shareholder Yield | 2.87% | 0.67% |
| Dividend Per Share | $2.66 | $1.28 |
| Dividend Growth (YoY) | 0.00% | 9.59% |
| Years of Dividend Growth | 0 | 0 |
| Payout Ratio | 69.9% | 26.1% |
| FCF Payout Ratio | 29.1% | 33.4% |
Shares
| Measure | Cvs Health | Industry median |
|---|---|---|
| Shares Outstanding | 1,278,970,000 | 42,514,400 |
| Shares Change (YoY) | 1.31% | 1.64% |
| Shares Change (QoQ) | 0.39% | 0.27% |
| Float | 1,273,460,000 | 37,225,800 |
| Shares Held by Insiders | 0.43% | 7.90% |
| Shares Held by Institutions | 89.2% | 50.2% |
Taxes
| Measure | Cvs Health | Industry median |
|---|---|---|
| Income Tax | $902.00M | $1.09M |
| Effective Tax Rate | 15.6% | 22.8% |
Scores
| Measure | Cvs Health | Industry median |
|---|---|---|
| Graham Number | $72.71 | $26.68 |
| Graham Upside | -21.6% | -44.0% |
| Altman Z-Score | 2.46 | 1.50 |
| Piotroski F-Score | 7 | 5 |
Calculated by StockData from Cvs Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.